News PhRMA Report Looks at Decade of Progress in Treating MS and Other Chronic Diseases PhRMA Report Looks at Decade of Progress in Treating MS and Other Chronic Diseases by Patricia Silva, PhD | March 1, 2016 Share this article: Share article via email Copy article link AĀ PhRMA report, titled “A Decade of Innovation in Chronic Diseases,” examined advances made in the treatment of several chronic health conditions, including multiple sclerosis (MS), over the past 10 years that have helped patients to avoid disease complications and hospitalizations, and improve their quality of life. Chronic diseases such as MS, diabetes, high cholesterol, rheumatoid arthritis, HIV/AIDS, and hepatitis C, are among the most complex and important healthcare challenges of our time, both in human and financial terms, PhRMA reported. Seven out of 10Ā deaths in the United States are due to chronic health conditions, and about half of all American adults have one or more of these diseases.Ā Patients with chronic diseases are also frequent users of medical care, accounting for 81 percent of all hospital admissions and 76Ā percentĀ of physician visits. Treating theseĀ diseases is hugely expensive, withĀ 86 centsĀ of every healthcare dollar spent inĀ the U.S. going toward aĀ chronic illness. However, in the last decade, the biopharmaceutical industry has made notableĀ progress in better treating these disorders, the organization said in a press release. In the years leading up to 2006, for instance,Ā MS patients had several treatment options that were effective, and a number are still in use. However, these medicines were usually injected or infused, and often resulted in painful site reactions and challenging side effects. Between 2006 and 2016, in contrast, the report noted that the number of MS treatment options ā and their means of administration āĀ has expanded in important ways. Currently, three oral disease-modifying medicines are available, offering more convenient therapy options with fewer side effects. MS patients can better choose how and when to take their medication to fit their needs, increasing overall compliance and leading to better treatment outcomes. Today, a total of 40 medicines are being developed to treat the disease, withĀ several aimed atĀ patients with progressive MS who currently lack treatment options. Similar biopharmaceuticalĀ advances in the treatment of diabetes, HIV/AIDs, cholesterol, and rheumatoid arthritis are alsoĀ highlightedĀ in the report. MS is a chronic autoimmune disorder in which the immune system mistakenly attacks myelin, a substance that coats nerve fibers. The disease affects more than 400,000 Americans and 2.3 million people worldwide. MS can emerge at any age, but people living with MS are often diagnosed between the ages of 20 and 50. Common MS symptoms include fatigue, walking difficulties, numbness, spasticity, muscle stiffness, vision, bladder and Ā sexual problems, pain, cognitive and emotional changes, and depression. PhRMA,Ā orĀ the Pharmaceutical Research and Manufacturers of America, is an organization representing major biopharmaceutical researchers and biotechnology companiesĀ in the U.S. Print This Page About the Author Patricia Silva, PhD PatrĆcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĆcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles. Tags treatment
April 24, 2024 News by Lindsey Shapiro, PhD Autoantibodies seen in blood years before MS diagnosis: Study
April 23, 2024 News by Mary Chapman Itās year 10 for MSAAās upcoming Improving Lives Benefit for MS
April 23, 2024 News by Margarida Maia, PhD AAN 2024: Subcutaneous Ocrevus led to nearly no relapses after year